Association of the trajectory of plasma aldosterone concentration with the risk of cardiovascular disease in patients with hypertension: a cohort study

被引:17
作者
Cai, Xintian [1 ]
Song, Shuaiwei [1 ]
Hu, Junli [1 ]
Zhu, Qing [1 ]
Shen, Di [1 ]
Yang, Wenbo [1 ]
Ma, Huimin [1 ]
Luo, Qin [1 ]
Hong, Jing [1 ]
Zhang, Delian [1 ]
Li, Nanfang [1 ]
机构
[1] Peoples Hosp Xinjiang Uygur Autonomous Reg, Xinjiang Clin Med Res Ctr Hypertens Cardio Cerebro, Hypertens Ctr, Xinjiang Hypertens Inst,NHC Key Lab Hypertens Clin, 91 Tianchi Rd, Urumqi 830001, Xinjiang, Peoples R China
关键词
BLOOD-PRESSURE; HEART-FAILURE; RENAL-DISEASE; MORTALITY; EVENTS; MANAGEMENT; MEDIATOR; BURDEN; STROKE; DEATH;
D O I
10.1038/s41598-024-54971-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The purpose of this study was to determine the long-term pattern of plasma aldosterone concentration (PAC) trajectories and to explore the relationship between PAC trajectory patterns and cardiovascular disease (CVD) risk in patients with hypertension. Participants were surveyed three times between 2010 and 2016, and latent mixed modeling was employed to determine the trajectory of PAC over the exposure period (2010-2016). A Cox regression analysis was used to examine the association between PAC trajectory patterns and the risk of CVD (stroke and myocardial infarction). Hazard ratios (HRs) with corresponding 95% confidence intervals (CIs) were calculated and reported. During a median follow-up of 4.10 (3.37-4.50) years, 82 incident CVD cases (33 myocardial infarction cases and 49 stroke cases) were identified. Among all three PAC models, the high-stability PAC pattern exhibited the highest risk of CVD. After full adjustment for all covariables, HRs were 2.19 (95% CI 1.59-3.01) for the moderate-stable pattern and 2.56 (95% CI 1.68-3.91) for the high-stable pattern in comparison to the low-stable pattern. Subgroup and sensitivity analyses verified this association. The presence of a high-stable PAC trajectory pattern is associated with an elevated risk of CVD in hypertensive patients. Nevertheless, more studies are warranted to confirm these findings.
引用
收藏
页数:8
相关论文
共 47 条
[1]   Transition to heart failure in hypertension: going to the heart of the matter [J].
Bayes-Genis, Antoni ;
Diez, Javier .
EUROPEAN HEART JOURNAL, 2022, 43 (35) :3332-3334
[2]   High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction [J].
Beygui, Farzin ;
Collet, Jean-Philippe ;
Benoliel, Jean-Jacques ;
Vignolles, Nicolas ;
Dumaine, Raphaelle ;
Barthelemy, Olivier ;
Montalescot, Gilles .
CIRCULATION, 2006, 114 (24) :2604-2610
[3]   Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis [J].
Brown, Nancy J. .
NATURE REVIEWS NEPHROLOGY, 2013, 9 (08) :459-469
[4]   Aldosterone as a Mediator of Cardiovascular Damage [J].
Buffolo, Fabrizio ;
Tetti, Martina ;
Mulatero, Paolo ;
Monticone, Silvia .
HYPERTENSION, 2022, 79 (09) :1899-1911
[5]   Aldosterone and cardiovascular disease - Smoke and fire [J].
Calhoun, David A. .
CIRCULATION, 2006, 114 (24) :2572-2574
[6]   A lifetime of aldosterone excess: Long-term consequences of altered regulation of aldosterone production for cardiovascular function [J].
Connell, John M. C. ;
MacKenzie, Scott M. ;
Freel, E. Marie ;
Fraser, Robert ;
Davies, Eleanor .
ENDOCRINE REVIEWS, 2008, 29 (02) :133-154
[7]   Serum Aldosterone and Death, End-Stage Renal Disease, and Cardiovascular Events in Blacks and Whites Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study [J].
Deo, Rajat ;
Yang, Wei ;
Khan, Abigail M. ;
Bansal, Nisha ;
Zhang, Xiaoming ;
Leonard, Mary B. ;
Keane, Martin G. ;
Soliman, Elsayed Z. ;
Steigerwalt, Susan ;
Townsend, Raymond R. ;
Shlipak, Michael G. ;
Feldman, Harold I. .
HYPERTENSION, 2014, 64 (01) :103-110
[8]   Aldosterone as a mediator of progressive renal disease: Pathogenetic and clinical implications [J].
Epstein, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) :677-688
[9]   Aldosterone and Mineralocorticoid Receptors in the Cardiovascular System [J].
Funder, John W. .
PROGRESS IN CARDIOVASCULAR DISEASES, 2010, 52 (05) :393-400
[10]   Aldosterone and Cardiovascular Disease [J].
Gaddam, Krishna K. ;
Pimenta, Eduardo ;
Husain, Saima ;
Calhoun, David A. .
CURRENT PROBLEMS IN CARDIOLOGY, 2009, 34 (02) :51-84